Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asym./Biol. Unit - manually
(-)Asym./Biol. Unit
(-)Asym./Biol. Unit - sites
collapse expand < >
Image Asym./Biol. Unit - manually
Asym./Biol. Unit - manually  (Jmol Viewer)
Image Asym./Biol. Unit
Asym./Biol. Unit  (Jmol Viewer)
Image Asym./Biol. Unit - sites
Asym./Biol. Unit - sites  (Jmol Viewer)

(-) Description

Title :  EXTRACELLULAR DOMAIN OF THE LDL RECEPTOR
 
Authors :  G. Rudenko, L. Henry, K. Henderson, K. Ichtchenko, M. S. Brown, J. L. Gol J. Deisenhofer
Date :  13 Nov 02  (Deposition) - 21 Jan 03  (Release) - 13 Jul 11  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  3.70
Chains :  Asym./Biol. Unit :  A
Keywords :  Ldl-Receptor, Familial Hypercholesterolemia, Ldl, Cholesterol Metabolism, Lipid Transport (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  G. Rudenko, L. Henry, K. Henderson, K. Ichtchenko, M. S. Brown, J. L. Goldstein, J. Deisenhofer
Structure Of The Ldl Receptor Extracellular Domain At Endosomal Ph
Science V. 298 2353 2002
PubMed-ID: 12459547  |  Reference-DOI: 10.1126/SCIENCE.1078124

(-) Compounds

Molecule 1 - LOW-DENSITY LIPOPROTEIN RECEPTOR
    ChainsA
    EngineeredYES
    Expression SystemTRICHOPLUSIA NI
    Expression System CommonCABBAGE LOOPER
    Expression System Taxid7111
    Expression System Vector TypeBACULOVIRUS
    FragmentEXTRACELLULAR DOMAIN, RESIDUES 1-699
    GeneLDLR
    MutationYES
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymLDL RECEPTOR

 Structural Features

(-) Chains, Units

  1
Asymmetric/Biological Unit A

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (5, 20)

Asymmetric/Biological Unit (5, 20)
No.NameCountTypeFull Name
1BMA2Ligand/IonBETA-D-MANNOSE
2CA8Ligand/IonCALCIUM ION
3KEG3Ligand/Ion12-TUNGSTOPHOSPHATE
4MAN3Ligand/IonALPHA-D-MANNOSE
5NAG4Ligand/IonN-ACETYL-D-GLUCOSAMINE

(-) Sites  (20, 20)

Asymmetric Unit (20, 20)
No.NameEvidenceResiduesDescription
01AC1SOFTWAREPHE A:132 , GLN A:133 , ASN A:135 , GLY A:155 , GLN A:161 , NAG A:2031BINDING SITE FOR RESIDUE NAG A 2030
02AC2SOFTWARENAG A:2030 , BMA A:2032BINDING SITE FOR RESIDUE NAG A 2031
03AC3SOFTWARENAG A:2031 , MAN A:2033 , MAN A:2035BINDING SITE FOR RESIDUE BMA A 2032
04AC4SOFTWAREBMA A:2032BINDING SITE FOR RESIDUE MAN A 2033
05AC5SOFTWAREBMA A:2032BINDING SITE FOR RESIDUE MAN A 2035
06AC6SOFTWAREASN A:251 , VAL A:252 , ASN A:570 , NAG A:3031BINDING SITE FOR RESIDUE NAG A 3030
07AC7SOFTWAREASN A:667 , NAG A:3030 , BMA A:3032BINDING SITE FOR RESIDUE NAG A 3031
08AC8SOFTWARENAG A:3031 , MAN A:3033BINDING SITE FOR RESIDUE BMA A 3032
09AC9SOFTWAREBMA A:3032BINDING SITE FOR RESIDUE MAN A 3033
10BC1SOFTWARETHR A:294 , ASN A:295 , GLU A:296 , ASP A:310 , LEU A:311 , LYS A:312 , ILE A:313 , TYR A:315BINDING SITE FOR RESIDUE CA A 1001
11BC2SOFTWAREASP A:333 , ILE A:334 , GLU A:336 , ASN A:349 , LEU A:350BINDING SITE FOR RESIDUE CA A 1002
12BC3SOFTWARETRP A:193 , ASP A:196 , GLY A:198 , ASP A:200 , ASP A:206 , GLU A:207 , LYS A:582BINDING SITE FOR RESIDUE CA A 1003
13BC4SOFTWAREARG A:232 , GLN A:233 , CYS A:234 , ASP A:235 , GLU A:237 , ASP A:239 , ASP A:245 , GLU A:246BINDING SITE FOR RESIDUE CA A 1004
14BC5SOFTWARELYS A:273 , ASN A:276 , ASP A:280 , ASP A:286 , GLU A:287BINDING SITE FOR RESIDUE CA A 1005
15BC6SOFTWAREASP A:147 , ASP A:149 , ASP A:151 , ASP A:157BINDING SITE FOR RESIDUE CA A 1006
16BC7SOFTWAREPHE A:105 , ASP A:108 , ASP A:110 , ASP A:112 , ASP A:118 , GLU A:119BINDING SITE FOR RESIDUE CA A 1007
17BC8SOFTWARETRP A:66 , ASP A:69 , GLN A:71 , ASP A:73 , ASP A:79 , GLU A:80BINDING SITE FOR RESIDUE CA A 1008
18BC9SOFTWAREGLY A:55BINDING SITE FOR RESIDUE KEG A 6001
19CC1SOFTWAREARG A:103 , GLN A:104 , SER A:449 , ARG A:450BINDING SITE FOR RESIDUE KEG A 6002
20CC2SOFTWAREARG A:385 , ASN A:407BINDING SITE FOR RESIDUE KEG A 6003

(-) SS Bonds  (26, 26)

Asymmetric/Biological Unit
No.Residues
1A:47 -A:61
2A:54 -A:74
3A:68 -A:83
4A:95 -A:113
5A:107 -A:122
6A:127 -A:139
7A:134 -A:152
8A:146 -A:163
9A:176 -A:188
10A:183 -A:201
11A:195 -A:210
12A:215 -A:227
13A:222 -A:240
14A:234 -A:249
15A:255 -A:268
16A:263 -A:281
17A:275 -A:292
18A:297 -A:308
19A:304 -A:317
20A:319 -A:331
21A:337 -A:347
22A:343 -A:356
23A:358 -A:371
24A:646 -A:660
25A:656 -A:675
26A:677 -A:690

(-) Cis Peptide Bonds  (1, 1)

Asymmetric/Biological Unit
No.Residues
1Asp A:339 -Pro A:340

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (170, 170)

Asymmetric/Biological Unit (170, 170)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
001UniProtVAR_005308W87GLDLR_HUMANDisease (FH)121908025AW66G
002UniProtVAR_005309C89YLDLR_HUMANDisease (FH)875989894AC68Y
003UniProtVAR_005310D90GLDLR_HUMANDisease (FH)771019366AD69G
004UniProtVAR_005311D90NLDLR_HUMANDisease (FH)749038326AD69N
005UniProtVAR_005312D90YLDLR_HUMANDisease (FH)749038326AD69Y
006UniProtVAR_005313Q92ELDLR_HUMANDisease (FH)774467219AQ71E
007UniProtVAR_005314C95GLDLR_HUMANDisease (FH)879254456AC74G
008UniProtVAR_005315E101KLDLR_HUMANDisease (FH)144172724AE80K
009UniProtVAR_059375P105SLDLR_HUMANPolymorphism13306510AP84S
010UniProtVAR_005316C109RLDLR_HUMANPolymorphism140807148AC88R
011UniProtVAR_005317C116RLDLR_HUMANDisease (FH)879254482AC95R
012UniProtVAR_062371C134FLDLR_HUMANDisease (FH)879254514AC113F
013UniProtVAR_062372C134WLDLR_HUMANDisease (FH)879254515AC113W
014UniProtVAR_065780D139HLDLR_HUMANPolymorphism879254517AD118H
015UniProtVAR_005318E140KLDLR_HUMANDisease (FH)748944640AE119K
016UniProtVAR_072828C143RLDLR_HUMANDisease (FH)875989901AC122R
017UniProtVAR_072829C148YLDLR_HUMANDisease (FH)879254526AC127Y
018UniProtVAR_005319C155GLDLR_HUMANPolymorphism879254535AC134G
019UniProtVAR_072830C155YLDLR_HUMANDisease (FH)879254536AC134Y
020UniProtVAR_005320C160YLDLR_HUMANUnclassified (FH)879254541AC139Y
021UniProtVAR_072831D168ALDLR_HUMANUnclassified (FH)  ---AD147A
022UniProtVAR_005321D168HLDLR_HUMANDisease (FH)200727689AD147H
023UniProtVAR_005322D168NLDLR_HUMANDisease (FH)200727689AD147N
024UniProtVAR_005323D168YLDLR_HUMANDisease (FH)200727689AD147Y
025UniProtVAR_013950D172HLDLR_HUMANPolymorphism879254554AD151H
026UniProtVAR_072832D172NLDLR_HUMANDisease (FH)879254554AD151N
027UniProtVAR_005324C173RLDLR_HUMANPolymorphism879254558AC152R
028UniProtVAR_005325C173WLDLR_HUMANDisease (FH)769318035AC152W
029UniProtVAR_005326D175NLDLR_HUMANDisease (FH)121908033AD154N
030UniProtVAR_007981D175YLDLR_HUMANDisease (FH)121908033AD154Y
031UniProtVAR_005327S177LLDLR_HUMANDisease (FH)121908026AS156L
032UniProtVAR_072833C184WLDLR_HUMANDisease (FH)879254571AC163W
033UniProtVAR_013951C184YLDLR_HUMANDisease (FH)121908039AC163Y
034UniProtVAR_005328C197FLDLR_HUMANPolymorphism376459828AC176F
035UniProtVAR_005330C197RLDLR_HUMANDisease (FH)730882085AC176R
036UniProtVAR_005329C197YLDLR_HUMANPolymorphism376459828AC176Y
037UniProtVAR_065781E201KLDLR_HUMANPolymorphism879254589AE180K
038UniProtVAR_072834H211LLDLR_HUMANUnclassified (FH)879254603AH190L
039UniProtVAR_005332D221GLDLR_HUMANDisease (FH)373822756AD200G
040UniProtVAR_007982D221NLDLR_HUMANDisease (FH)875989906AD200N
041UniProtVAR_005333D221YLDLR_HUMANDisease (FH)875989906AD200Y
042UniProtVAR_062373C222YLDLR_HUMANDisease (FH)730882086AC201Y
043UniProtVAR_005335D224GLDLR_HUMANPolymorphism879254630AD203G
044UniProtVAR_005334D224NLDLR_HUMANPolymorphism387906303AD203N
045UniProtVAR_005336D224VLDLR_HUMANDisease (FH)879254630AD203V
046UniProtVAR_005337S226PLDLR_HUMANPolymorphism879254635AS205P
047UniProtVAR_005338D227ELDLR_HUMANDisease (FH)121908028AD206E
048UniProtVAR_005341E228KLDLR_HUMANDisease (FH)121908029AE207K
049UniProtVAR_005340E228QLDLR_HUMANUnclassified (FH)121908029AE207Q
050UniProtVAR_005342C231GLDLR_HUMANDisease (FH)746091400AC210G
051UniProtVAR_005343E240KLDLR_HUMANPolymorphism768563000AE219K
052UniProtVAR_072835C243RLDLR_HUMANUnclassified (FH)879254659AC222R
053UniProtVAR_005344C248FLDLR_HUMANPolymorphism879254663AC227F
054UniProtVAR_005345C248YLDLR_HUMANDisease (FH)879254663AC227Y
055UniProtVAR_013952R253WLDLR_HUMANPolymorphism150673992AR232W
056UniProtVAR_062374Q254PLDLR_HUMANDisease (FH)879254667AQ233P
057UniProtVAR_065782C255SLDLR_HUMANPolymorphism879254668AC234S
058UniProtVAR_005346D256GLDLR_HUMANPolymorphism879254670AD235G
059UniProtVAR_072836R257WLDLR_HUMANPolymorphism200990725AR236W
060UniProtVAR_013953C261FLDLR_HUMANDisease (FH)121908040AC240F
061UniProtVAR_005347D266ELDLR_HUMANUnclassified (FH)139043155AD245E
062UniProtVAR_005348C270YLDLR_HUMANPolymorphism879254683AC249Y
063UniProtVAR_062375C276RLDLR_HUMANDisease (FH)879254692AC255R
064UniProtVAR_072837C276WLDLR_HUMANUnclassified (FH)  ---AC255W
065UniProtVAR_005349C276YLDLR_HUMANDisease (FH)730882089AC255Y
066UniProtVAR_005350E277KLDLR_HUMANUnclassified (FH)148698650AE256K
067UniProtVAR_072838H285YLDLR_HUMANUnclassified (FH)730882091AH264Y
068UniProtVAR_005351S286RLDLR_HUMANUnclassified (FH)140241383AS265R
069UniProtVAR_007983E288KLDLR_HUMANDisease (FH)368657165AE267K
070UniProtVAR_072839R300GLDLR_HUMANDisease (FH)767618089AR279G
071UniProtVAR_005352D301ALDLR_HUMANDisease (FH)879254714AD280A
072UniProtVAR_072840D301GLDLR_HUMANDisease (FH)879254714AD280G
073UniProtVAR_005354C302WLDLR_HUMANDisease (FH)879254716AC281W
074UniProtVAR_005353C302YLDLR_HUMANDisease (FH)879254715AC281Y
075UniProtVAR_005356D304ELDLR_HUMANPolymorphism875989909AD283E
076UniProtVAR_005355D304NLDLR_HUMANPolymorphism121908030AD283N
077UniProtVAR_005357S306LLDLR_HUMANUnclassified (FH)11547917AS285L
078UniProtVAR_005358C313YLDLR_HUMANDisease (FH)875989910AC292Y
079UniProtVAR_072841G314RLDLR_HUMANUnclassified (FH)72658858AG293R
080UniProtVAR_005360C318FLDLR_HUMANDisease (FH)879254739AC297F
081UniProtVAR_062376C318RLDLR_HUMANDisease (FH)879254738AC297R
082UniProtVAR_005359C318YLDLR_HUMANPolymorphism879254739AC297Y
083UniProtVAR_072842S326CLDLR_HUMANUnclassified (FH)879254747AS305C
084UniProtVAR_005361H327YLDLR_HUMANDisease (FH)747507019AH306Y
085UniProtVAR_067196C329FLDLR_HUMANDisease (FH)  ---AC308F
086UniProtVAR_005362C329YLDLR_HUMANDisease (FH)761954844AC308Y
087UniProtVAR_005363G335SLDLR_HUMANPolymorphism544453230AG314S
088UniProtVAR_005364C338SLDLR_HUMANDisease (FH)879254753AC317S
089UniProtVAR_005365D342ELDLR_HUMANUnclassified  ---AD321E
090UniProtVAR_005366D342NLDLR_HUMANUnclassified (FH)139361635AD321N
091UniProtVAR_005367G343SLDLR_HUMANUnclassified (FH)730882096AG322S
092UniProtVAR_005368R350PLDLR_HUMANDisease (FH)875989914AR329P
093UniProtVAR_072843C352RLDLR_HUMANUnclassified (FH)879254769AC331R
094UniProtVAR_005369C352YLDLR_HUMANPolymorphism193922566AC331Y
095UniProtVAR_005370D354GLDLR_HUMANPolymorphism755449669AD333G
096UniProtVAR_005371D354VLDLR_HUMANUnclassified  ---AD333V
097UniProtVAR_007984D356YLDLR_HUMANDisease (FH)  ---AD335Y
098UniProtVAR_005372E357KLDLR_HUMANPolymorphism879254781AE336K
099UniProtVAR_062377C358YLDLR_HUMANDisease (FH)875989915AC337Y
100UniProtVAR_005373C364RLDLR_HUMANPolymorphism879254787AC343R
101UniProtVAR_007985Q366RLDLR_HUMANDisease (FH)746982741AQ345R
102UniProtVAR_005374C368RLDLR_HUMANDisease (FH)  ---AC347R
103UniProtVAR_072844C368YLDLR_HUMANUnclassified (FH)768430352AC347Y
104UniProtVAR_062378N370TLDLR_HUMANDisease (FH)879254792AN349T
105UniProtVAR_072845G373DLDLR_HUMANUnclassified (FH)879254797AG352D
106UniProtVAR_005375C379RLDLR_HUMANPolymorphism879254803AC358R
107UniProtVAR_007986C379YLDLR_HUMANDisease (FH)879254804AC358Y
108UniProtVAR_024519A391TLDLR_HUMANPolymorphism11669576AA370T
109UniProtVAR_005376A399DLDLR_HUMANDisease (FH)875989918AA378D
110UniProtVAR_005377L401HLDLR_HUMANPolymorphism121908038AL380H
111UniProtVAR_007987L401VLDLR_HUMANDisease (FH)146200173AL380V
112UniProtVAR_008995F403LLDLR_HUMANDisease (FH)879254831AF382L
113UniProtVAR_072846T404PLDLR_HUMANUnclassified (FH)879254834AT383P
114UniProtVAR_013954R406QLDLR_HUMANPolymorphism552422789AR385Q
115UniProtVAR_072847R406WLDLR_HUMANUnclassified (FH)121908043AR385W
116UniProtVAR_005378E408KLDLR_HUMANUnclassified (FH)137943601AE387K
117UniProtVAR_005379L414RLDLR_HUMANDisease (FH)748554592AL393R
118UniProtVAR_062379D415GLDLR_HUMANDisease (FH)879254845AD394G
119UniProtVAR_005380R416QLDLR_HUMANDisease (FH)773658037AR395Q
120UniProtVAR_005381R416WLDLR_HUMANDisease (FH)570942190AR395W
121UniProtVAR_005382I423TLDLR_HUMANDisease (FH)879254849AI402T
122UniProtVAR_005383V429MLDLR_HUMANDisease (FH)28942078AV408M
123UniProtVAR_005384A431TLDLR_HUMANUnclassified (FH)28942079AA410T
124UniProtVAR_007988L432VLDLR_HUMANDisease (FH)730882100AL411V
125UniProtVAR_005385D433HLDLR_HUMANDisease (FH)121908036AD412H
126UniProtVAR_005386T434KLDLR_HUMANUnclassified (FH)  ---AT413K
127UniProtVAR_005388I441MLDLR_HUMANUnclassified  ---AI420M
128UniProtVAR_005387I441NLDLR_HUMANPolymorphism879254862AI420N
129UniProtVAR_072848Y442HLDLR_HUMANUnclassified (FH)879254863AY421H
130UniProtVAR_005389W443CLDLR_HUMANPolymorphism879254867AW422C
131UniProtVAR_062380I451TLDLR_HUMANDisease (FH)879254874AI430T
132UniProtVAR_072849T454NLDLR_HUMANDisease (FH)879254879AT433N
133UniProtVAR_011863V468ILDLR_HUMANPolymorphism5932AV447I
134UniProtVAR_065783R471GLDLR_HUMANPolymorphism879254891AR450G
135UniProtVAR_005390G478RLDLR_HUMANPolymorphism144614838AG457R
136UniProtVAR_062381L479PLDLR_HUMANDisease (FH)879254900AL458P
137UniProtVAR_005391D482HLDLR_HUMANDisease (FH)  ---AD461H
138UniProtVAR_005392W483RLDLR_HUMANDisease (FH)879254905AW462R
139UniProtVAR_005394H485RLDLR_HUMANPolymorphism879254906AH464R
140UniProtVAR_072850D492NLDLR_HUMANUnclassified (FH)373646964AD471N
141UniProtVAR_005395V523MLDLR_HUMANDisease (FH)28942080AV502M
142UniProtVAR_005396P526SLDLR_HUMANUnclassified (FH)730882106AP505S
143UniProtVAR_005397G546DLDLR_HUMANPolymorphism28942081AG525D
144UniProtVAR_005398G549DLDLR_HUMANDisease (FH)28941776AG528D
145UniProtVAR_005399N564HLDLR_HUMANDisease (FH)28942086AN543H
146UniProtVAR_005400N564SLDLR_HUMANDisease (FH)758194385AN543S
147UniProtVAR_005401G565VLDLR_HUMANPolymorphism28942082AG544V
148UniProtVAR_008996L568VLDLR_HUMANDisease (FH)  ---AL547V
149UniProtVAR_072851R574CLDLR_HUMANDisease (FH)185098634AR553C
150UniProtVAR_072852R574HLDLR_HUMANUnclassified (FH)777188764AR553H
151UniProtVAR_072853W577GLDLR_HUMANDisease (FH)879255000AW556G
152UniProtVAR_072854W577SLDLR_HUMANUnclassified (FH)138947766AW556S
153UniProtVAR_005402D579NLDLR_HUMANDisease (FH)  ---AD558N
154UniProtVAR_062382D579YLDLR_HUMANDisease (FH)875989929AD558Y
155UniProtVAR_072855I585TLDLR_HUMANUnclassified (FH)879255012AI564T
156UniProtVAR_005403G592ELDLR_HUMANDisease (FH)137929307AG571E
157UniProtVAR_072856R595WLDLR_HUMANUnclassified (FH)373371572AR574W
158UniProtVAR_005404L599SLDLR_HUMANPolymorphism879255025AL578S
159UniProtVAR_072857D601HLDLR_HUMANUnclassified (FH)  ---AD580H
160UniProtVAR_007989P608SLDLR_HUMANDisease (FH)879255034AP587S
161UniProtVAR_005405R633CLDLR_HUMANDisease (FH)746118995AR612C
162UniProtVAR_072858V639DLDLR_HUMANDisease (FH)794728584AV618D
163UniProtVAR_005406P649LLDLR_HUMANDisease (FH)879255081AP628L
164UniProtVAR_005407C667YLDLR_HUMANDisease (FH)28942083AC646Y
165UniProtVAR_005408C677RLDLR_HUMANDisease (FH)775092314AC656R
166UniProtVAR_005409L682PLDLR_HUMANPolymorphism879255119AL661P
167UniProtVAR_005410P685LLDLR_HUMANDisease (FH)28942084AP664L
168UniProtVAR_013955P699LLDLR_HUMANUnclassified (FH)201573863AP678L
169UniProtVAR_005412D700ELDLR_HUMANDisease (FH)759858813AD679E
170UniProtVAR_008997E714KLDLR_HUMANDisease (FH)869320652AE693K

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (7, 24)

Asymmetric/Biological Unit (7, 24)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1LDLRA_2PS50068 LDL-receptor class A (LDLRA) domain profile.LDLR_HUMAN26-64
67-105
108-144
147-185
196-232
235-271
275-314
  6-
A:46-84
A:87-123
A:126-164
A:175-211
A:214-250
A:254-293
2LDLRA_1PS01209 LDL-receptor class A (LDLRA) domain signature.LDLR_HUMAN39-63
82-104
121-143
160-184
209-231
248-270
289-313
  6-
A:61-83
A:103-122
A:139-163
A:188-210
A:227-249
A:268-292
3EGF_3PS50026 EGF-like domain profile.LDLR_HUMAN314-353
354-393
  2A:293-332
A:333-372
4ASX_HYDROXYLPS00010 Aspartic acid and asparagine hydroxylation site.LDLR_HUMAN329-340
368-379
  2A:308-319
A:347-358
5EGF_2PS01186 EGF-like domain signature 2.LDLR_HUMAN338-352
377-392
  2A:317-331
A:356-371
6EGF_CAPS01187 Calcium-binding EGF-like domain signature.LDLR_HUMAN354-377  1A:333-356
7LDLRBPS51120 LDL-receptor class B (LDLRB) repeat profile.LDLR_HUMAN439-485
486-528
529-572
573-617
618-658
  5A:418-464
A:465-507
A:508-551
A:552-596
A:597-637

(-) Exons   (0, 0)

(no "Exon" information available for 1N7D)

(-) Sequences/Alignments

Asymmetric/Biological Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:639
 aligned with LDLR_HUMAN | P01130 from UniProtKB/Swiss-Prot  Length:860

    Alignment length:650
                                    74        84        94       104       114       124       134       144       154       164       174       184       194       204       214       224       234       244       254       264       274       284       294       304       314       324       334       344       354       364       374       384       394       404       414       424       434       444       454       464       474       484       494       504       514       524       534       544       554       564       574       584       594       604       614       624       634       644       654       664       674       684       694       704       714
           LDLR_HUMAN    65 SVTCKSGDFSCGGRVNRCIPQFWRCDGQVDCDNGSDEQGCPPKTCSQDEFRCHDGKCISRQFVCDSDRDCLDGSDEASCPVLTCGPASFQCNSSTCIPQLWACDNDPDCEDGSDEWPQRCRGLYVFQGDSSPCSAFEFHCLSGECIHSSWRCDGGPDCKDKSDEENCAVATCRPDEFQCSDGNCIHGSRQCDREYDCKDMSDEVGCVNVTLCEGPNKFKCHSGECITLDKVCNMARDCRDWSDEPIKECGTNECLDNNGGCSHVCNDLKIGYECLCPDGFQLVAQRRCEDIDECQDPDTCSQLCVNLEGGYKCQCEEGFQLDPHTKACKAVGSIAYLFFTNRHEVRKMTLDRSEYTSLIPNLRNVVALDTEVASNRIYWSDLSQRMICSTQLDRAHGVSSYDTVISRDIQAPDGLAVDWIHSNIYWTDSVLGTVSVADTKGVKRKTLFRENGSKPRAIVVDPVHGFMYWTDWGTPAKIKKGGLNGVDIYSLVTENIQWPNGITLDLLSGRLYWVDSKLHSISSIDVNGGNRKTILEDEKRLAHPFSLAVFEDKVFWTDIINEAIFSANRLTGSDVNLLAENLLSPEDMVLFHNLTQPRGVNWCERTTLSNGGCQYLCLPAPQINPHSPKFTCACPDGMLLARDMRSCLTE 714
               SCOP domains d1n7da5 A:44-  83                       d1n7da6 A:84-12    4                     d1n7da7 A:125-174                                 d1n7da8 A:175-211                    d1n7da9 A:212-251                       d1n7daa A:252-295                           d1n7da2 A:296-332                    d1n7da3 A:333-376                           d1n7da1 A:3 77-642 Low density lipoprotein (LDL) receptor                                                                                                                                                                                                                 d1n7da4 A:643-693                                   SCOP domains
               CATH domains 1n7dA01 A:44-  96 Low-density L ipoprotein Receptor  --    --------------------------------------------------------------------1n7dA04 A:171-212                         ----------------------------------------------------------------------------------1n7dA07 A:295-332 Laminin             1n7dA08 A:333-377 Laminin                    1n7dA09 A: 378-642 TolB, C-terminal domain                                                                                                                                                                                                                               1n7dA10 A:643-693 Laminin                           CATH domains
           Pfam domains (1) -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Ldl_recept_a-1n7dA07 A:253-292          ----------------------------------------EGF_CA-1n7dA06 A:333-371               -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Ldl_recept_b-1n7dA01 A:595-635           ---------------------------------------------------------- Pfam domains (1)
           Pfam domains (2) -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Ldl_recept_a-1n7dA08 A:253-292          --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Ldl_recept_b-1n7dA02 A:595-635           ---------------------------------------------------------- Pfam domains (2)
           Pfam domains (3) -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Ldl_recept_a-1n7dA09 A:253-292          --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Ldl_recept_b-1n7dA03 A:595-635           ---------------------------------------------------------- Pfam domains (3)
           Pfam domains (4) -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Ldl_recept_a-1n7dA10 A:253-292          --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Ldl_recept_b-1n7dA04 A:595-635           ---------------------------------------------------------- Pfam domains (4)
           Pfam domains (5) -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Ldl_recept_a-1n7dA11 A:253-292          --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Ldl_recept_b-1n7dA05 A:595-635           ---------------------------------------------------------- Pfam domains (5)
           Pfam domains (6) -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Ldl_recept_a-1n7dA12 A:253-292          ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains (6)
         Sec.struct. author .............--................-.......................----....................................................................................................................eee.....eee..............................................................................................................................................................-.ee......ee............eee....eeee........eeee......-...........--...ee........ee.......eeee......eeee..........ee........ee........ee..........ee..........eee......eeeee....eeeee.......eee.............eee..eeeee......eeeee...eeeee..............................................................ee......ee.. Sec.struct. author
             SAPs(SNPs) (1) ----------------------G-YG-E--G-----K---S---R------R-----------------F----HK--R----Y------G----Y-------A---HR-N-L------W------------F---K---------L---------GY-G-PEK--G--------K--R----F----WPSGW---F----E---Y-----RK-------YR-K-----------GAW-E-L------YR---F-------CY-F-----S--S---ES------P-R-G-YKY-----R-R-R-T--D-----R-----------T-------D-H-LP-Q-K-----RGQ------T-----M-TVHK------MHC-------T--N-------------I--G------RP--HR-R------N------------------------------M--S-------------------D--D--------------HV--V-----C--G-N-----T------E--W---S-H------S------------------------C-----D---------L-----------------Y---------R----P--L-------------LE-------------K SAPs(SNPs) (1)
             SAPs(SNPs) (2) -------------------------N-------------------------------------------W--------------------Y------------H---NW-Y--------Y------------R-----------------------N--N---Q-------------------Y---------------------------W------------------------GY-N-------------R----------Y------------N---------Y-V-------------Y----------Y---------------------V----W---------W------------------------N--------------------------------------------------------------------------------------------------------------------------S---------H--S-Y--------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) -------------------------Y-----------------------------------------------------------------------------N----------------------------Y-----------------------Y--V---------------------------------------------------Y-----------------------------------------Y------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ SAPs(SNPs) (3)
             SAPs(SNPs) (4) -------------------------------------------------------------------------------------------------------Y------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ SAPs(SNPs) (4)
                PROSITE (1) --LDLRA_2  PDB: A:46-84 UniProt: 67-105  --LDLRA_2  PDB: A:87-123               --LDLRA_2  PDB: A:126-164                ----------LDLRA_2  PDB: A:175-211              --LDLRA_2  PDB: A:214-250              ---LDLRA_2  PDB: A:254-293 UniProt: 275-314--------------ASX_HYDROXYL-------------EGF_3  PDB: A:333-372 UniProt: 354-393  ---------------------------------------------LDLRB  PDB: A:418-464 UniProt: 439-485         LDLRB  PDB: A:465-507 UniProt: 486-528     LDLRB  PDB: A:508-551 UniProt: 529-572      LDLRB  PDB: A:552-596 UniProt: 573-617       LDLRB  PDB: A:597-637 UniProt: 618-658   -------------------------------------------------------- PROSITE (1)
                PROSITE (2) -----------------LDLRA_1  PDB: A:61-83  ----------------LDLRA_1  PDB: A:103-122----------------LDLRA_1  PDB: A:139-163  ------------------------LDLRA_1  PDB: A:188-210----------------LDLRA_1  PDB: A:227-249------------------LDLRA_1  PDB: A:268-292  EGF_3  PDB: A:293-332 UniProt: 314-353  --------------ASX_HYDROXYL----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE (2)
                PROSITE (3) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------EGF_2           ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE (3)
                PROSITE (4) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------EGF_CA  PDB: A:333-356  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE (4)
                 Transcript -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript
                 1n7d A  44 SVTCKSGDFSCGG--NRCIPQFWRCDGQVDC-NGSDEQGCPPKTCSQDEFRCHDG----RQFVCDSDRDCLDGSDEASCPVLTCGPASFQCNSSTCIPQLWACDNDPDCEDGSDEWPQRCRGLYVFQGDSSPCSAFEFHCLSGECIHSSWRCDGGPDCKDKSDEENCAVATCRPDEFQCSDGNCIHGSRQCDREYDCKDMSDEVGCVNVTLCEGPNKFKCHSGECITLDKVCNMARDCRDWSDEPIKECGTNECLDNNGGCSHVCNDLKIGYECLCPDGFQLVAQRRCEDIDECQDPDTCSQLCVNLEGGYKCQCEEGFQLDPHTKACKAVGSIAYLFFTNRHE-RKMTLDRSEYTSLIPNLRNVVALDTEVASNRIYWSDLSQRMICSTQLDRAHG-SSYDTVISRDI--PDGLAVDWIHSNIYWTDSVLGTVSVADTKGVKRKTLFREQGSKPRAIVVDPVHGFMYWTDWGTPAKIKKGGLNGVDIYSLVTENIQWPNGITLDLLSGRLYWVDSKLHSISSIDVNGGNRKTILEDEKRLAHPFSLAVFEDKVFWTDIINEAIFSANRLTGSDVNLLAENLLSPEDMVLFHQLTQPRGVNWCERTTLSNGGCQYLCLPAPQINPHSPKFTCACPDGMLLARDMRSCLTE 693
                                    53  |  |  63        73| |     83        93    |  103       113       123       133       143       153       163       173       183       193       203       213       223       233       243       253       263       273       283       293       303       313       323       333       343       353       363       373       383   | | 393       403       413       423       433      |443        |- |     463       473       483       493       503       513       523       533       543       553       563       573       583       593       603       613       623       633       643       653       663       673       683       693
                                       56 59             74 |                    98  103                                                                                                                                                                                                                                                                                         387 |                                                440 |       452  |                                                                                                                                                                                                                                              
                                                           76                                                                                                                                                                                                                                                                                                                      389                                                  442          455                                                                                                                                                                                                                                              

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (3, 10)

Asymmetric/Biological Unit

(-) CATH Domains  (3, 6)

Asymmetric/Biological Unit
(-)
Class: Mainly Beta (13760)

(-) Pfam Domains  (3, 12)

Asymmetric/Biological Unit
(-)
Clan: EGF (60)

(-) Gene Ontology  (50, 50)

Asymmetric/Biological Unit(hide GO term definitions)
Chain A   (LDLR_HUMAN | P01130)
molecular function
    GO:0005509    calcium ion binding    Interacting selectively and non-covalently with calcium ions (Ca2+).
    GO:0032050    clathrin heavy chain binding    Interacting selectively and non-covalently with a clathrin heavy chain.
    GO:0042802    identical protein binding    Interacting selectively and non-covalently with an identical protein or proteins.
    GO:0030169    low-density lipoprotein particle binding    Interacting selectively and non-covalently with a low-density lipoprotein particle, a lipoprotein particle that is rich in cholesterol esters and low in triglycerides, is typically composed of APOB100 and APOE, and has a density of 1.02-1.06 g/ml and a diameter of between 20-25 nm.
    GO:0005041    low-density lipoprotein receptor activity    Combining with a low-density lipoprotein particle and delivering the low-density lipoprotein into the cell via endocytosis.
    GO:0002020    protease binding    Interacting selectively and non-covalently with any protease or peptidase.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0004872    receptor activity    Combining with an extracellular or intracellular messenger to initiate a change in cell activity.
    GO:0030229    very-low-density lipoprotein particle receptor activity    Combining with a very-low-density lipoprotein particle and delivering the very-low-density lipoprotein into the cell via endocytosis.
    GO:0001618    virus receptor activity    Combining with a virus component and mediating entry of the virus into the cell.
biological process
    GO:0042632    cholesterol homeostasis    Any process involved in the maintenance of an internal steady state of cholesterol within an organism or cell.
    GO:0070508    cholesterol import    The directed movement of cholesterol into a cell or organelle.
    GO:0008203    cholesterol metabolic process    The chemical reactions and pathways involving cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones. It is a component of the plasma membrane lipid bilayer and of plasma lipoproteins and can be found in all animal tissues.
    GO:0030301    cholesterol transport    The directed movement of cholesterol, cholest-5-en-3-beta-ol, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
    GO:0006897    endocytosis    A vesicle-mediated transport process in which cells take up external materials or membrane constituents by the invagination of a small region of the plasma membrane to form a new membrane-bounded vesicle.
    GO:0030299    intestinal cholesterol absorption    Uptake of cholesterol into the blood by absorption from the small intestine.
    GO:0006629    lipid metabolic process    The chemical reactions and pathways involving lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. Includes fatty acids; neutral fats, other fatty-acid esters, and soaps; long-chain (fatty) alcohols and waxes; sphingoids and other long-chain bases; glycolipids, phospholipids and sphingolipids; and carotenes, polyprenols, sterols, terpenes and other isoprenoids.
    GO:0006869    lipid transport    The directed movement of lipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Lipids are compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent.
    GO:0042159    lipoprotein catabolic process    The chemical reactions and pathways resulting in the breakdown of any conjugated, water-soluble protein in which the covalently attached nonprotein group consists of a lipid or lipids.
    GO:0042157    lipoprotein metabolic process    The chemical reactions and pathways involving any conjugated, water-soluble protein in which the covalently attached nonprotein group consists of a lipid or lipids.
    GO:0034383    low-density lipoprotein particle clearance    The process in which a low-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.
    GO:0015914    phospholipid transport    The directed movement of phospholipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Phospholipids are any lipids containing phosphoric acid as a mono- or diester.
    GO:0010867    positive regulation of triglyceride biosynthetic process    Any process that increases the rate, frequency, or extent of triglyceride biosynthesis. Triglyceride biosynthesis is the collection of chemical reactions and pathways resulting in the formation of triglyceride, any triester of glycerol.
    GO:0006898    receptor-mediated endocytosis    An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.
    GO:2000188    regulation of cholesterol homeostasis    Any process that modulates the frequency, rate or extent of cholesterol homeostasis.
    GO:0010899    regulation of phosphatidylcholine catabolic process    Any process that modulates the rate, frequency or extent of phosphatidylcholine catabolism. Phosphatidylcholine catabolic processes are the chemical reactions and pathways resulting in the breakdown of phosphatidylcholines, any of a class of glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of choline.
    GO:0008202    steroid metabolic process    The chemical reactions and pathways involving steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus.
    GO:0006810    transport    The directed movement of substances (such as macromolecules, small molecules, ions) or cellular components (such as complexes and organelles) into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter, pore or motor protein.
    GO:0046718    viral entry into host cell    The process that occurs after viral attachment by which a virus, or viral nucleic acid, breaches the plasma membrane or cell envelope and enters the host cell. The process ends when the viral nucleic acid is released into the host cell cytoplasm.
    GO:0016032    viral process    A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle.
cellular component
    GO:0005794    Golgi apparatus    A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
    GO:1990666    PCSK9-LDLR complex    A protein complex consisting of the serine protease PCSK9 (Proprotein convertase subtilisin/kexin-9) and a low-density lipoprotein receptor (LDLR). Interaction typically occurs through the epidermal growth factor-like repeat A (EGF-A) domain of the LDLR, and complex formation promotes degradation of the LDLR through the endosome/lysosome pathway.
    GO:0045177    apical part of cell    The region of a polarized cell that forms a tip or is distal to a base. For example, in a polarized epithelial cell, the apical region has an exposed surface and lies opposite to the basal lamina that separates the epithelium from other tissue.
    GO:0016323    basolateral plasma membrane    The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis.
    GO:0009986    cell surface    The external part of the cell wall and/or plasma membrane.
    GO:0030669    clathrin-coated endocytic vesicle membrane    The lipid bilayer surrounding a clathrin-coated endocytic vesicle.
    GO:0005905    clathrin-coated pit    A part of the endomembrane system in the form of an invagination of a membrane upon which a clathrin coat forms, and that can be converted by vesicle budding into a clathrin-coated vesicle. Coated pits form on the plasma membrane, where they are involved in receptor-mediated selective transport of many proteins and other macromolecules across the cell membrane, in the trans-Golgi network, and on some endosomes.
    GO:0005769    early endosome    A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways.
    GO:0012505    endomembrane system    A collection of membranous structures involved in transport within the cell. The main components of the endomembrane system are endoplasmic reticulum, Golgi bodies, vesicles, cell membrane and nuclear envelope. Members of the endomembrane system pass materials through each other or though the use of vesicles.
    GO:0005768    endosome    A vacuole to which materials ingested by endocytosis are delivered.
    GO:0010008    endosome membrane    The lipid bilayer surrounding an endosome.
    GO:0009897    external side of plasma membrane    The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
    GO:0016021    integral component of membrane    The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0005887    integral component of plasma membrane    The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0005770    late endosome    A prelysosomal endocytic organelle differentiated from early endosomes by lower lumenal pH and different protein composition. Late endosomes are more spherical than early endosomes and are mostly juxtanuclear, being concentrated near the microtubule organizing center.
    GO:0034362    low-density lipoprotein particle    A lipoprotein particle, rich in cholesterol esters and low in triglycerides that is typically composed of APOB100 and APOE and has a density of 1.02-1.06 g/ml and a diameter of between 20-25 nm. LDL particles are formed from VLDL particles (via IDL) by the loss of triglyceride and gain of cholesterol ester. They transport endogenous cholesterol (and to some extent triglycerides) from peripheral tissues back to the liver.
    GO:0005764    lysosome    A small lytic vacuole that has cell cycle-independent morphology and is found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
    GO:0043235    receptor complex    Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.

 Visualization

(-) Interactive Views

Asymmetric/Biological Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    BMA  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    CA  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    KEG  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    MAN  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    NAG  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
    AC5  [ RasMol ]  +environment [ RasMol ]
    AC6  [ RasMol ]  +environment [ RasMol ]
    AC7  [ RasMol ]  +environment [ RasMol ]
    AC8  [ RasMol ]  +environment [ RasMol ]
    AC9  [ RasMol ]  +environment [ RasMol ]
    BC1  [ RasMol ]  +environment [ RasMol ]
    BC2  [ RasMol ]  +environment [ RasMol ]
    BC3  [ RasMol ]  +environment [ RasMol ]
    BC4  [ RasMol ]  +environment [ RasMol ]
    BC5  [ RasMol ]  +environment [ RasMol ]
    BC6  [ RasMol ]  +environment [ RasMol ]
    BC7  [ RasMol ]  +environment [ RasMol ]
    BC8  [ RasMol ]  +environment [ RasMol ]
    BC9  [ RasMol ]  +environment [ RasMol ]
    CC1  [ RasMol ]  +environment [ RasMol ]
    CC2  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    Asp A:339 - Pro A:340   [ RasMol ]  
 

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  1n7d
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  LDLR_HUMAN | P01130
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  (no 'Enzyme Classificator' available)
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  143890
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  LDLR_HUMAN | P01130
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        LDLR_HUMAN | P011301ajj 1d2j 1f5y 1f8z 1hj7 1hz8 1i0u 1ijq 1ldl 1ldr 1lrx 1xfe 2fcw 2kri 2lgp 2m7p 2mg9 2w2m 2w2n 2w2o 2w2p 2w2q 3bps 3gcw 3gcx 3m0c 3p5b 3p5c 3so6 4ne9

(-) Related Entries Specified in the PDB File

(no "Related Entries Specified in the PDB File" available for 1N7D)